Revolutionary new prostate cancer test can be used at home

Revolutionary new prostate cancer test can be used at home

Revolutionary new prostate cancer test can be used at home

And feedback from the participants showed that the at-home test was preferable.

Lead researcher Dr. Jeremy Clark, from UEA's Norwich Medical School, said: "Prostate cancer is the most common cancer in men in the UK".

It is also suitable for men already diagnosed with low risk disease who are on a "watch and wait" approach known as active surveillance.

Critics argue, however, the so-called benefits are "misleading" and the study "too small to draw any conclusions". "With the ability to merely supply a urine pattern at domestic and publish a pattern off for research may just truly revolutionise the analysis", Clark added.

■ THE number of cancer sufferers in the United Kingdom has risen by almost a fifth in five years to nearly 3million.

There is no screening programme for the disease because "it has not been proved the benefits outweigh the risks", the NHS reports.

Men more than 50 are qualified for a "PSA" blood test which gives specialists an unpleasant thought of whether a patient is in danger.

Many prostate tumours are slowing growing and non-aggressive.

Thousands of men are put off seeking a diagnosis because of the known side effects from treatment, including erectile dysfunction. The results showed that all the fault was overexpression of BRN4 and interaction with another transcription factor in the same family, BRN2, forcing cancer cells of the prostate gland to develop in neuroendocrine cells.

"However, doctors struggle to predict which tumours will become aggressive, making it hard to decide on treatment for many men".

To check its effectiveness, men attending Norfolk and Norwich University Hospital urology clinics were asked to use the test on their first urine of the day.

'Since the prostate is continually emitting, the assortment of pee from men's first pee of the day implies that the biomarker levels from the prostate are a lot higher and progressively steady, so this is an extraordinary improvement.

And the research team hope that the introduction of the "At-Home Collection Kit" could revolutionize diagnosis of the disease.

It was surprising to see that the "at-home collection" sample provides the biomarkers of prostate cancer clearly than the rectal examination.

"The usage of our At House take a look at may just in long run revolutionise how the ones on "energetic surveillance" are monitored for illness development, with males best having to seek advice from the health center for a favorable urine effect".

Active surveillance monitors early prostate cancer that has not spread, according to Prostate Cancer UK. It usually develops slowly and the majority of cancers will not require treatment in a man's lifetime. "That is against this to the present scenario the place males are recalled to the health center each six to 12 months for painful and costly biopsies", persevered Clark.

The test, pioneered by the University of East Anglia (UEA) and Norfolk and Norwich University Hospital (NNUH), involves collecting a urine sample and can measure the aggressiveness of prostate cancer as well as predicting much earlier than standard methods whether patients will require treatment.

Experts behind the Prostate Urine Risk test, from the University of East Anglia and the Norfolk and Norwich University Hospital, say they have now developed the test further so urine samples can be collected at home. It's able to pick up how aggressive the disease is and at what point men will need treatment, as well as ruling out those who do not have the disease.

However, not everyone is convinced.

Dr Mangesh Thorat, deputy director of the Cancer Prevention Trials Unit at King's College London, said: 'They found that "at-home" samples are at least as good as samples in the clinic. They juxtaposed the home collection samples with the one collected after digital rectal examination.

Related news

[an error occurred while processing the directive]